Select Medical (NYSE:SEM) Issues Earnings Results

Select Medical (NYSE:SEM) released its earnings results on Thursday. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11), Zacks reports. The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.50 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. Select Medical updated its FY 2025 guidance to 1.090-1.190 EPS.

Select Medical Stock Performance

NYSE:SEM traded down $1.95 during mid-day trading on Friday, hitting $17.12. The stock had a trading volume of 733,188 shares, compared to its average volume of 780,408. Select Medical has a twelve month low of $16.20 and a twelve month high of $40.98. The stock has a market cap of $2.22 billion, a price-to-earnings ratio of 7.98, a PEG ratio of 0.64 and a beta of 1.45. The company’s 50 day simple moving average is $19.13 and its 200 day simple moving average is $28.07. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Insider Activity at Select Medical

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares of the company’s stock, valued at $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have issued reports on SEM shares. Royal Bank of Canada increased their target price on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a report on Friday. Finally, UBS Group decreased their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $39.50.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.